![Crossject](/common/images/company/EU_ALCJ.png)
Successful completion of an additional Registration Batch of ZEPIZURE® at new manufacturing siteMilestone complements the satisfying results from previous batches under stability studies, and is...
Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE® Fabrication réussie d’un autre Lot Règlementaire de ZEPIZURE® sur le nouveau site de fabricationUne étape importante qui...
Crossject to attend H.C. Wainwright 26th Annual Global Investment Conference Dijon, France, July 15th 2024, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company...
Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright Dijon, France, 15 juillet 2024, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), société...
Key contribution to the acceleration of the development of ZENEO® EpinephrineFinancial support includes mainly grants, as well as subsidized loansFrance 2030 Plan dedicated to supporting French...
Crossject obtient 6,9 millions d'euros de financement public dans le cadre du plan France 2030, pour accélérer le développement de ZENEO® Adrénaline Contribution clé à l'accélération du...
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 5 juillet 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), «...
Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study Landmark RAMPART study established midazolam...
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 18 juin 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), «...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.096 | -5.05263157895 | 1.9 | 1.9 | 1.784 | 32623 | 1.82948753 | DE |
4 | 0.064 | 3.67816091954 | 1.74 | 2.04 | 1.58 | 62022 | 1.79177101 | DE |
12 | -0.176 | -8.88888888889 | 1.98 | 2.54 | 1.52 | 86011 | 1.91204378 | DE |
26 | -3.426 | -65.5066921606 | 5.23 | 5.39 | 1.52 | 102009 | 2.7432443 | DE |
52 | -1.951 | -51.9573901465 | 3.755 | 5.96 | 1.52 | 81605 | 3.42366907 | DE |
156 | -1.001 | -35.6862745098 | 2.805 | 5.96 | 1.408 | 86032 | 3.36388897 | DE |
260 | 0.384 | 27.0422535211 | 1.42 | 5.96 | 1.04 | 135177 | 3.01530426 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.